Literature DB >> 8043061

The spectrum of severe rheumatic mitral valve disease in a developing country. Correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae.

R H Marcus1, P Sareli, W A Pocock, J B Barlow.   

Abstract

OBJECTIVE: To describe the demographic, pathologic, and hemodynamic profiles of patients with severe rheumatic mitral valve disease in a developing country and to assess their relation to uncontrolled rheumatic disease activity.
DESIGN: Retrospective, cross-sectional, cohort study.
SETTING: Tertiary medical center in Soweto, South Africa. PATIENTS: 714 of 737 consecutive black patients, 4 to 73 years old, with pure mitral regurgitation, pure mitral stenosis, or mixed mitral disease who had mitral valve surgery and in whom preoperative and surgical data were concordant. MEASUREMENTS: Valve lesions were evaluated on the basis of clinical, echocardiographic, hemodynamic, and surgical pathologic data. Active rheumatic carditis was diagnosed according to clinical evidence for concurrent acute rheumatic fever (Jones criteria), macroscopic appearances at surgery, and histologic findings.
RESULTS: 219 patients had pure mitral regurgitation, 275 had pure mitral stenosis, and 220 had mixed lesions. Ongoing rheumatic activity was diagnosed in 106 patients with pure regurgitation (47%) and in only 5 patients with pure stenosis (2%). Pure regurgitation was the most common lesion in the first and second decades; the relative prevalence of pure stenosis increased with age. Purely regurgitant valves had pliable, unscarred leaflets (95%), dilated mitral annuli (95%), elongated chordae tendineae (92%), and anterior leaflet prolapse (81%). In contrast, purely stenotic valves had fused leaflet commissures (100%) and rigid leaflets (38%) but no evidence of prolapse.
CONCLUSIONS: The spectrum of rheumatic mitral valve disease that is hemodynamically severe in developing countries differs from that currently reported in the United States. Severe, pure rheumatic mitral regurgitation is as prevalent as pure stenosis but has an entirely different time course, surgical anatomy, and relation to disease activity, suggesting a separate pathophysiologic mechanism.

Entities:  

Mesh:

Year:  1994        PMID: 8043061     DOI: 10.7326/0003-4819-120-3-199402010-00001

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  30 in total

Review 1.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

Review 2.  Basic mechanisms of mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Jonathan Beaudoin; Mark D Handschumacher; Robert A Levine
Journal:  Can J Cardiol       Date:  2014-07-02       Impact factor: 5.223

Review 3.  Management of tricuspid valve regurgitation.

Authors:  Manuel J Antunes; John B Barlow
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

Review 4.  Prevention and treatment of rheumatic heart disease in the developing world.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Nat Rev Cardiol       Date:  2009-09-15       Impact factor: 32.419

5.  Mitral valve geometry in paediatric rheumatic mitral regurgitation.

Authors:  Michael Yeong; Marcus Silbery; Kirsten Finucane; Nigel J Wilson; Thomas L Gentles
Journal:  Pediatr Cardiol       Date:  2015-01-06       Impact factor: 1.655

Review 6.  Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity.

Authors:  Soumya D Chakravarty; John B Zabriskie; Allan Gibofsky
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

Review 7.  Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.

Authors:  Vuyisile T Nkomo
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

Review 8.  Endovascular Therapy for Rheumatic Mitral and Aortic Valve Disease: Review Article.

Authors:  Tesfaye Telila; Elsayed Mohamed; Kurt M Jacobson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-22

9.  Effect of mitral valve replacement on left ventricular function in subjects with severe rheumatic mitral regurgitation.

Authors:  Sharen Maharaj; Somalingum Ponnusamy; Datshana Naidoo
Journal:  Cardiovasc J Afr       Date:  2021-02-12       Impact factor: 1.167

10.  The spectrum of rheumatic mitral valve regurgitation presenting to Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, over a 10-year period.

Authors:  Nomthandazo Lynn Zwane; Somalingum Ponnusamy; Datshana Prakesh Naidoo
Journal:  Cardiovasc J Afr       Date:  2021-03-16       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.